NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis

R. Van Dijck, M. ter Borg, B. van der Holt, A. E. C. Broers, M. D. Hazenberg, J. J. Cornelissen, N. P. M. Schaap, E. de Pater, P. A. W. te Boekhorst
British Journal of Haematology · Wiley · 2026-11-10 · DOI: 10.1111/bjh.70811

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles